- Home
- NMFC vs OPK Comparison
NMFC vs OPK Comparison
Compare NMFC & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMFC
- OPK
- Stock Information
- Founded
- NMFC 2010
- OPK 2007
- Country
- NMFC United States
- OPK United States
- Employees
- NMFC N/A
- OPK N/A
- Industry
- NMFC Finance/Investors Services
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- NMFC Finance
- OPK Health Care
- Exchange
- NMFC Nasdaq
- OPK Nasdaq
- Market Cap
- NMFC 1.2B
- OPK 1.1B
- IPO Year
- NMFC 2011
- OPK 1995
- Fundamental
- Price
- NMFC $8.98
- OPK $1.56
- Analyst Decision
- NMFC Hold
- OPK Buy
- Analyst Count
- NMFC 3
- OPK 3
- Target Price
- NMFC $10.33
- OPK $2.63
- AVG Volume (30 Days)
- NMFC 991.5K
- OPK 2.5M
- Earning Date
- NMFC 11-03-2025
- OPK 11-06-2025
- Dividend Yield
- NMFC 14.22%
- OPK N/A
- EPS Growth
- NMFC N/A
- OPK N/A
- EPS
- NMFC 0.77
- OPK N/A
- Revenue
- NMFC $355,675,000.00
- OPK $664,029,000.00
- Revenue This Year
- NMFC N/A
- OPK N/A
- Revenue Next Year
- NMFC N/A
- OPK $0.84
- P/E Ratio
- NMFC $11.73
- OPK N/A
- Revenue Growth
- NMFC N/A
- OPK N/A
- 52 Week Low
- NMFC $8.84
- OPK $1.11
- 52 Week High
- NMFC $12.05
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- NMFC 22.95
- OPK 61.80
- Support Level
- NMFC $9.46
- OPK $1.53
- Resistance Level
- NMFC $9.67
- OPK $1.60
- Average True Range (ATR)
- NMFC 0.19
- OPK 0.05
- MACD
- NMFC -0.05
- OPK 0.00
- Stochastic Oscillator
- NMFC 0.52
- OPK 76.19
About NMFC New Mountain Finance Corporation
New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.